BPC-157
Also known as: Body Protection Compound 157, Gastric pentadecapeptide, BPC 157
Gastric pentadecapeptide used for tissue and gut repair. SubQ for systemic and musculoskeletal targets, oral for GI-tract healing. Avoid NSAIDs, which blunt its healing effect.
Pharmacokinetics
- Half-life
- 30 min
- Time to peak
- 30 min
- Bioavailability
- 80%
- Dosing interval
- 12h
Administration
- Primary routes
- SubQ, Oral
- Category
- Healing & Repair
Safety Flags
- High immunogenicity
- Contraindicated in cancer history
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 5 outcome protocols
- Injury RepairPrimary
Accelerate healing of tendons, ligaments, muscles, and other soft tissues
Safe default: 250mcg · twice daily · SubQ
- Increased Strength
Enhance muscular strength through IGF-1 pathway activation
Safe default: 250mcg · twice daily · SubQ
- Cellular Repair
Activate telomerase and support cellular longevity mechanisms
Safe default: 250mcg · twice daily · SubQ
- Gut HealingPrimary
Repair intestinal barrier function and reduce gut permeability
Safe default: 500mcg · daily (oral, on empty stomach) · SubQ
- Inflammation
Reduce systemic inflammation and inflammatory markers
Safe default: 250mcg · twice daily · SubQ
Simulate BPC-157
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.